Executive ManagementRichard Allen
Mr. Allen co-founded RTI Biologics (Nasdaq:RTIX), a medical device company with proprietary technology in orthopedics and tissue regeneration, and led the company's IPO in August 2000. In addition to RTIX, he has co-founded several successful medical technology companies, including Axogen (Nasdaq:AXGN)(peripheral nerve regeneration), ViewRay (beam-on MRI-guided radiation therapy devices), OrthoHelix (small bone orthopedics), Optima Neuroscience (neural monitoring technology), RegisterPatient.com (cloud-based patient registration), and HyGreen (a spinoff company from Xhale that markets a novel electronic hand hygiene monitoring and reminding system). Mr. Allen also co-founded Synogen, a private equity medical technology venture fund, and Emergent Growth Fund, a technology investment fund. He is a CPA and has served on the boards of numerous companies.
Kevin M. Quilty
Executive Vice President of Sales
Mr. Quilty has been a driving force behind the success of multiple medical device and healthcare service companies for over 35 years. Most recently, he served as CEO of Bioseal a privately held medical device manufacturer of custom single-use items used in the operating room, surgery centers and hospitals. Previously he served as Senior Vice President of Sales & Marketing as well as Chief Operating Officer for Endocare, Inc. Mr. Quilty developed the global strategy that successfully launched cryoablation technology for the treatment of prostate cancer and ablation of tumors in kidney, lung, liver and bone. Kevin built a global sales and marketing team of 50 individuals that generated revenue of $32 million.
Mr. Quilty was also Executive Vice President of Market Operations and Sales for Pointshare Corporation where he pioneered online business services. As Senior Vice President of Sales and Marketing for Paidos Health Management Services, he catapulted revenue by 45% by cultivating new markets in New York, Connecticut, Florida, and Texas. Mr. Quilty spearheaded joint ventures with leading academic centers as Chief Executive Officer of Qaulidx, LLC.
Mr. Quilty holds a Bachelor of Science degree in political science from the State University of New York at Oneonta.
Ronald E. Youngblood II, B.S.
Executive Vice President of Operations
Mr. Youngblood is a graduate of the University of Florida, with a degree in Resource Economics. He has over 25 years of manufacturing experience, spanning all aspects from planning and hands-on development to managing processes and associates. Mr. Youngblood spent 14 years with Honeywell International, primarily with Honeywell’s Guidance and Navigation Operations center in Clearwater, Florida. There, he was responsible for development and manufacture of inertial guidance systems with embedded GPS capability that are currently in use on a multitude of aircraft and missiles worldwide. While at Honeywell, Mr. Youngblood was trained and certified as an expert in Demand Flow and Lean Manufacturing, and completed extensive specialized training in Root Cause and Corrective Action processes.
In 1998, Mr. Youngblood joined the startup company Regeneration Technologies, Inc. in Alachua, Florida and became Manager of Spinal Allograft Manufacturing, reporting directly to the Vice President of Operations. In 2000 Mr. Youngblood supported a successful IPO that helped position RTI as a world leader in the biomedical industry. During his tenure, he managed all aspects of biomedical manufacturing in both human and bovine production from initial concept through product launch utilizing state of the art machining, a highly skilled staff and the trademarked Biocleanse sterilization process.
In 2006, Mr. Youngblood joined the startup company Xhale Inc. in Gainesville, Florida and became Vice President of Operations reporting directly to the CEO. Mr. Youngblood has been instrumental in the product development and commercialization of both Xhale Inc. and HyGreen lines and oversees all Engineering , Manufacturing and Installation activities on a national level.
Richard J. Melker, M.D., Ph.D.
Chief Technology Officer
Dr. Melker, co-founder and Chief Technology Officer with Xhale, received his Ph.D. (Neurobiology) and M.D. degrees from Albert Einstein College of Medicine. After a residency in Pediatrics, and fellowships in Pediatric Cardiology and Critical Care Medicine, he served as Director of Emergency Services at Shands Hospital at the University of Florida College of Medicine, as well as Medical Liaison for the NASA space shuttle program. He holds the position of Professor of Anesthesiology, Pediatrics and Biomedical Engineering at U.F. and since 1993 has been Director of the Florida Anesthesiology Computer and Engineering Team (FACET) which develops and licenses medical devices and technologies. Dr. Melker holds over 35 issued U.S. patents including several for emergency medical devices in use throughout the world, and by the U.S. Special Forces.
Elena Fraser, MBA
Vice President of Marketing
Elena Fraser has more than 20 years of experience in the marketing and design. At Xhale, Ms. Fraser is the Director of Marketing for HyGreen and manages Business Development and Marketing for the Xhale’s pharmaceutical division. She was with the University of Florida for over 17 years in the College of Public Health and Health Professions and was the project manager for the Rehabilitation Engineering Research Center. Her last four years were as director of the International Conference on Aging and Disability, bringing researchers, academicians and policy leaders from all over the world to discuss the issues of aging and disability. Over the years, Ms. Fraser has edited 29 publications, co-authored five manuscripts, and written 17 successful grant applications. She has also volunteered marketing and PR services to several charities including Sustainable Cambodia, the NACD and Rotary.
Steven Todd Gold, Esq. J.D.,M.P.H.,M.B.E.
General Counsel & Vice President of Business Development
Mr. Gold provides in-house legal counsel to the company in addition to his position as the Vice President of Business Development. Mr. Gold is the primary contact for all corporate partnerships and other high level relationships for the Company. In addition to his legal background, Mr. Gold has extensive experience in private company formation, funding, and development of successful exit strategies. A graduate of Yale University (B.A.), the University of Florida Levin School of Law (J.D.), the University of Florida College of Medicine (M.P.H.) and the University of Pennsylvania School of Medicine Center for Bioethics (M.B.E.), Mr. Gold has previously served in the chambers of Justice Charles Wells of the Florida Supreme Court and has worked as a Deputy Solicitor General for the Florida Attorney General. He is barred in Florida, New Jersey and a number of appellate courts, including the United States Supreme Court.